.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Chinese Patent Office
Federal Trade Commission
US Department of Justice
US Army
Julphar
Covington
Daiichi Sankyo
Boehringer Ingelheim

Generated: June 27, 2017

DrugPatentWatch Database Preview

IDAMYCIN PFS Drug Profile

« Back to Dashboard

What is the patent landscape for Idamycin Pfs, and what generic Idamycin Pfs alternatives are available?

Idamycin Pfs is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in IDAMYCIN PFS is idarubicin hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.

Summary for Tradename: IDAMYCIN PFS

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list58
Clinical Trials: see list1,649
Patent Applications: see list5,009
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IDAMYCIN PFS at DailyMed

Pharmacology for Tradename: IDAMYCIN PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
IDAMYCIN PFS
idarubicin hydrochloride
INJECTABLE;INJECTION050734-001Feb 17, 1997APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Baxter
Citi
Chubb
Covington
Queensland Health
Mallinckrodt
McKesson
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot